发明公开
EP1412516A4 STRUCTURE-BASED DRUG DESIGN METHODS FOR IDENTIFYING D-ALA-D-ALA LIGASE INHIBITORS AS ANTIBACTERIAL DRUGS
审中-公开
主动设计工艺对结构基础一种判别D-ALA-D-ALA-连接酶抑制剂AS抗菌物质
- 专利标题: STRUCTURE-BASED DRUG DESIGN METHODS FOR IDENTIFYING D-ALA-D-ALA LIGASE INHIBITORS AS ANTIBACTERIAL DRUGS
- 专利标题(中): 主动设计工艺对结构基础一种判别D-ALA-D-ALA-连接酶抑制剂AS抗菌物质
-
申请号: EP02749688申请日: 2002-06-28
-
公开(公告)号: EP1412516A4公开(公告)日: 2004-09-08
- 发明人: NAVIA MANUEL A , ALA PAUL J , GRIFFITH JAMES P , ALI JANID A , FAERMAN CARLOS H , MOE SCOTT T , MAGEE ANDREW S , CONNELLY PATRICK R , PEROLA EMANUELE
- 申请人: ESSENTIAL THERAPEUTICS INC , PLIVA D D
- 专利权人: ESSENTIAL THERAPEUTICS INC,PLIVA D D
- 当前专利权人: ESSENTIAL THERAPEUTICS INC,PLIVA D D
- 优先权: US30167601 2001-06-28
- 主分类号: C12N9/00
- IPC分类号: C12N9/00 ; C12Q1/37
摘要:
The invention is based on the discovery that certain small molecules can bind to the ATP binding site of D-Ala-D-Ala ligase, even in the absence of the enzyme's substrate, and can cause a conformational change in the enzyme structure similar to that which occurs upon binding of ATP and substrate to the enzyme. Without wishing to be bound by any theory, it is believed that such a conformational change is required for either activation or inhibition of the enzyme. The information obtained from this discovery has enabled identification of key interactions in the active site of the enzyme, as well as the design and opimization of inhibitors.
信息查询